Literature DB >> 18684123

Development of a murine model to evaluate the effect of vernix caseosa on skin barrier recovery.

Marion H M Oudshoorn1, Robert Rissmann, Dennis van der Coelen, Wim E Hennink, Maria Ponec, Joke A Bouwstra.   

Abstract

The aim of this study was twofold, that is the generation of a reliable model for skin barrier disruption and repair and to evaluate recovery of damaged skin after application of vernix caseosa (VC). VC was selected as its wound healing properties were suggested previously, but never clearly demonstrated. Five different levels of barrier disruption in mice, accomplished by tape-stripping, were evaluated. Disruption models such as moderate, severe #1 and #2 (transepidermal water loss (TEWL) of 31 +/- 2, 59 +/- 4 and 66 +/- 3 g/m(2)/h, respectively) showed complete recovery within 72 h. However, not all corneocytes were removed after tape-stripping. Additionally, models such as severe #3 and #4 (TEWL of 73 +/- 5 and 79 +/- 6 g/m(2)/h, respectively) with a more severe disruption were evaluated. After tape-stripping, all corneocytes were removed and the remaining epidermis was intact. However, model #3 still showed complete recovery within 72 h. With model #4, a crust was formed and almost complete recovery (approximately 90%) was obtained within only 8 days. The effect of VC application on recovery of disrupted skin was evaluated with model #3 and #4. Model #3 showed that application of VC predominantly influenced initial recovery and is therefore merely appropriate to study the effect of formulations in the initial recovery period. Topical application of VC on model #4 considerably increased initial and long-term recovery. Moreover, VC application promoted rapid formation of stratum corneum and prevented epidermal thickening. These observations not only confirm the ability of VC to enhance barrier recovery, but also suggest potential use of this treatment clinically.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18684123     DOI: 10.1111/j.1600-0625.2008.00780.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  9 in total

Review 1.  The Ontogeny of Skin.

Authors:  Marty Visscher; Vivek Narendran
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-04-01       Impact factor: 4.730

2.  Topical hesperidin improves epidermal permeability barrier function and epidermal differentiation in normal murine skin.

Authors:  Maihua Hou; Mona Man; Wenyan Man; Wenyuan Zhu; Melanie Hupe; Kyungho Park; Debra Crumrine; Peter M Elias; Mao-Qiang Man
Journal:  Exp Dermatol       Date:  2012-05       Impact factor: 3.960

Review 3.  Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin.

Authors:  Mikolaj Milewski; Nicole K Brogden; Audra L Stinchcomb
Journal:  Expert Opin Drug Deliv       Date:  2010-05       Impact factor: 6.648

Review 4.  Epidermal Immunity and Function: Origin in Neonatal Skin.

Authors:  Marty O Visscher; Andrew N Carr; Vivek Narendran
Journal:  Front Mol Biosci       Date:  2022-06-08

5.  Applying a vernix caseosa based formulation accelerates skin barrier repair by modulating lipid biosynthesis.

Authors:  Walter A Boiten; Tineke Berkers; Samira Absalah; Jeroen van Smeden; Adriana P M Lavrijsen; Joke A Bouwstra
Journal:  J Lipid Res       Date:  2017-12-07       Impact factor: 5.922

6.  Expansion of epidermal progenitors with high p63 phosphorylation during wound healing of mouse epidermis.

Authors:  Daisuke Suzuki; Makoto Senoo
Journal:  Exp Dermatol       Date:  2013-05       Impact factor: 3.960

7.  Quantitative determination of skin penetration of PEG-coated CdSe quantum dots in dermabraded but not intact SKH-1 hairless mouse skin.

Authors:  Neera V Gopee; Dean W Roberts; Peggy Webb; Christy R Cozart; Paul H Siitonen; John R Latendresse; Alan R Warbitton; William W Yu; Vicki L Colvin; Nigel J Walker; Paul C Howard
Journal:  Toxicol Sci       Date:  2009-07-02       Impact factor: 4.849

8.  Skin barrier disruption by acetone: observations in a hairless mouse skin model.

Authors:  Robert Rissmann; Marion H M Oudshoorn; Wim E Hennink; Maria Ponec; Joke A Bouwstra
Journal:  Arch Dermatol Res       Date:  2009-04-07       Impact factor: 3.017

9.  Topically Applied Ceramides Interact with the Stratum Corneum Lipid Matrix in Compromised Ex Vivo Skin.

Authors:  Tineke Berkers; Dani Visscher; Gert S Gooris; Joke A Bouwstra
Journal:  Pharm Res       Date:  2018-02-06       Impact factor: 4.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.